Prime Medicine

PRME · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

NOV

7

Q3 2025

Reported

Reported earnings 3 months ago

Previous year: -$0.44

-27.3%

R&D Expenses

$44M

Previous year: $40.3M

+9.0%

G&A Expenses

$11.2M

Previous year: $14.1M

-20.5%

Total Operating Expenses

$55.2M

Previous year: $54.4M

+1.4%

Loading...

Prime Medicine

Unlock previous datapoints

Upgrade

Prime Medicine

Unlock previous datapoints

Upgrade

Prime Medicine Revenue by Segment

Revenue by Segment

Collaboration Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$688M

P/E Ratio

-1.28

Sector

N/A

Industry

N/A

52-Week High

$6.66

52-Week Low

$1.12

R&D Expenses

$44M

G&A Expenses

$11.2M

Total Operating Expenses

$55.2M

Net Loss

$50.6M

Total Liabilities

$223M

Products

Get in Touch

Resources

Prime Medicine

Prime Medicine

Prime Medicine

Prime Medicine Revenue by Segment

Revenue by Segment

Collaboration Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics